{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:32:27Z","timestamp":1792607547760,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AI141694"],"award-info":[{"award-number":["K23 AI141694"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR001424"],"award-info":[{"award-number":["KL2 TR001424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 145818"],"award-info":[{"award-number":["P01 145818"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI104733"],"award-info":[{"award-number":["R01 AI104733"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI106683"],"award-info":[{"award-number":["U19 AI106683"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaci.2020.04.031","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T10:42:39Z","timestamp":1588329759000},"page":"600-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease"],"prefix":"10.1016","volume":"147","author":[{"given":"Whitney W.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Staudacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Hulse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick G.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R.","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiam","family":"Abdala-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju T.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie C.","family":"Grammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline P.E.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Conley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Shintani-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.04.031_bib1","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/lary.27852","article-title":"Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps","volume":"129","author":"Bhattacharyya","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.04.031_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/alr.21674","article-title":"Prevalence of confirmed asthma varies in chronic rhinosinusitis subtypes","volume":"6","author":"Promsopa","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2020.04.031_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.04.031_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl\u00a07","key":"10.1016\/j.jaci.2020.04.031_bib5","first-page":"S1","article-title":"Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis","volume":"123","author":"Batra","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.04.031_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1067\/mai.2002.122458","article-title":"Chronic sinusitis in severe asthma is related to sputum eosinophilia","volume":"109","author":"ten Brinke","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2500\/ajra.2011.25.3613","article-title":"Association between severity of asthma and degree of chronic rhinosinusitis","volume":"25","author":"Lin","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2020.04.031_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2020.04.031_bib10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"Perez-Novo","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","article-title":"Impaired E Prostanoid2 expression and resistance to prostaglandin E2 in nasal polyp fibroblasts from subjects with aspirin-exacerbated respiratory disease","volume":"54","author":"Cahill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2020.04.031_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease--new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1164\/rccm.200811-1744OC","article-title":"Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells","volume":"179","author":"Zhao","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.jaci.2019.06.037","article-title":"Nasal polyps 15-lipoxygenase 1 promotes CCL26\/eotaxin3 expression through ERK activation","volume":"144","author":"Li","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in chronic rhinosinusitis. Role in eosinophilia and aspirin-exacerbated respiratory disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib18","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41586-018-0449-8","article-title":"Allergic inflammatory memory in human respiratory epithelial progenitor cells","volume":"560","author":"Ordovas-Montanes","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.04.031_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.plipres.2013.09.001","article-title":"The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor","volume":"52","author":"Powell","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.jaci.2020.04.031_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41588-018-0314-6","article-title":"A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis","volume":"51","author":"Kristjansson","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2020.04.031_bib21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbalip.2007.06.001","article-title":"Expression of 15-lipoxygenase type-1 in human mast cells","volume":"1771","author":"Gulliksson","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2020.04.031_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.jaci.2008.06.021","article-title":"12\/15-Lipoxygenase deficiency protects mice from allergic airways inflammation and increases secretory IgA levels","volume":"122","author":"Hajek","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.jaci.2008.02.018","article-title":"T-cell regulation in chronic paranasal sinus disease","volume":"121","author":"Van Bruaene","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jaci.2013.05.042","article-title":"Regional differences in the expression of innate host defense molecules in sinonasal mucosa","volume":"132","author":"Seshadri","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1748-1716.1980.tb06656.x","article-title":"Identification of 15-hydroxy-5,8,11,13-eicosatetraenoic acid (15-HETE) as a major metabolite of arachidonic acid in human lung","volume":"110","author":"Hamberg","year":"1980","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.jaci.2020.04.031_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0003-9861(90)90114-E","article-title":"15(S)-hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium","volume":"282","author":"Kumlin","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2020.04.031_bib27","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1073\/pnas.80.6.1712","article-title":"Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4","volume":"80","author":"Dahlen","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.04.031_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0003-9861(88)90048-3","article-title":"Metabolism of arachidonic acid by human nasal and bronchial epithelial cells","volume":"267","author":"Henke","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jaci.2020.04.031_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1288\/00005537-198702000-00009","article-title":"Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa","volume":"97","author":"Jung","year":"1987","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2020.04.031_bib30","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1046\/j.1365-2222.2002.01477.x","article-title":"Expression\u00a0and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition","volume":"32","author":"Chu","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2020.04.031_bib31","first-page":"501","article-title":"Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics","volume":"21B","author":"Picado","year":"1991","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1016\/j.jaci.2020.04.031_bib32","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1164\/ajrccm.149.4.8143059","article-title":"Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge","volume":"149","author":"Sladek","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/all.12512","article-title":"Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity","volume":"69","author":"Mastalerz","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.04.031_bib34","article-title":"Exhaled eicosanoids following bronchial aspirin challenge in asthma patients with and without aspirin hypersensitivity: the pilot study","volume":"2012","author":"Mastalerz","year":"2012","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.jaci.2020.04.031_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1164\/ajrccm.161.2.9902034","article-title":"Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients","volume":"161","author":"Kowalski","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2020.04.031_bib36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0091-6749(03)01716-0","article-title":"Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients","volume":"112","author":"Kowalski","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1165\/rcmb.2017-0031OC","article-title":"Preferential generation of 15-HETE-PE induced by IL-13 regulates goblet cell differentiation in human airway epithelial cells","volume":"57","author":"Zhao","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2020.04.031_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaip.2016.11.021","article-title":"Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease","volume":"5","author":"Jerschow","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.04.031_bib39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jaci.2012.02.046","article-title":"Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps","volume":"130","author":"Takabayashi","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.04.031_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/all.13489","article-title":"Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps","volume":"74","author":"Zhang","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2020.04.031_bib41","first-page":"449","article-title":"Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in\u00a0vitro","volume":"126","author":"Marom","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaci.2020.04.031_bib42","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1073\/pnas.1605957113","article-title":"Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99","volume":"113","author":"Bankova","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.04.031_bib43","doi-asserted-by":"crossref","first-page":"L730","DOI":"10.1152\/ajplung.00089.2003","article-title":"IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3-kinase regulation","volume":"285","author":"Atherton","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jaci.2020.04.031_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1165\/ajrcmb.25.6.4659","article-title":"Interleukin-13 induces\u00a0proliferation of human airway epithelial cells in\u00a0vitro via a mechanism mediated by transforming growth factor-alpha","volume":"25","author":"Booth","year":"2001","journal-title":"Am J Respir Cell Mol Biol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920306278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:27:13Z","timestamp":1789676833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920306278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0091674920306278"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}